No known drug interactions for the matched ingredients — not a guarantee none exist. Check your meds →
Dietary supplement

Proteolytic Enzymes Ingredients & Drug Interactions

by AMVILAB

Capsule Category: Non-nutrient/non-botanical
No known interaction
The interaction bottom line No known interaction

Proteolytic Enzymes is a dietary supplement by AMVILAB with 2 active ingredients. Its ingredients are commonly taken for swelling and inflammation after injury or surgery, wound and ulcer cleaning (topical), aiding digestion (in combination enzyme products).We don’t currently list a known drug interaction for its mapped ingredients — but that doesn’t guarantee none exist, so always confirm with your pharmacist.

HelloPharmacist Scorecard of Proteolytic Enzymes by AMVILAB

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

What’s inside

Low disclosure
Ingredient Transparency · database check
Low

Most active ingredients don't disclose an individual amount — you can't tell how much of each you're getting.

Why this rating?
  • The label discloses an exact amount for 0 of its 2 active ingredients.

This product has 2 active ingredients: trypsin and chymotrypsin. Both are proteolytic enzymes — proteins that break down other proteins.

Trypsin is a pancreatic enzyme used in wound and tissue repair; chymotrypsin is similar and has shown effectiveness for cataracts in the data we hold. The capsule also contains inactive ingredients (microcrystalline cellulose, hypromellose, magnesium stearate, and silicon dioxide) that help hold it together.

Does it work?

Not established
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
Not established

The graded evidence we hold for these ingredients covers different conditions than the ones this product is marketed for, so there's no established rating for its stated use.

Why this rating?
  • The label markets this product for: Support healthy inflammation response and wound healing.
  • We looked for evidence on: Postoperative swelling, Sprains, Wound healing, Exercise-induced muscle soreness, Burns, Fractures — and 3 related terms.
  • The closest evidence on file: Chymotrypsin is rated "Insufficient Reliable Evidence To Rate" for Burns (Natural Medicines).
  • Also on file: Chymotrypsin is rated "Insufficient Reliable Evidence To Rate" for Fractures.
  • Also on file: Trypsin is rated "Insufficient Reliable Evidence To Rate" for Exercise-induced muscle soreness, Wound healing, Sprains, Postoperative swelling.

The evidence here is mixed. Chymotrypsin has shown effectiveness for cataracts according to our data.

For trypsin and chymotrypsin together — including their use for sprains, osteoarthritis, radiation skin damage, wound healing, exercise-related muscle soreness, and multiple sclerosis — the evidence isn't established well enough for us to rate them. That doesn't mean they don't work; it means we don't have strong data yet.

The evidence, ingredient by ingredient Trypsin Chymotrypsin

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 2 of the 2 matched ingredients.
  • Pregnancy & breastfeeding safety ratings cover 2 of 2.
  • General safety write-ups exist for 2 of 2.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

Both enzymes are generally tolerated for short-term use, though quality evidence is limited. Trypsin can cause localized pain and burning if applied topically, and when taken by mouth alongside other enzymes it may cause mild-to-moderate stomach upset — nausea, heartburn, or stomach pain.

Chymotrypsin can rarely trigger serious allergic reactions, including anaphylaxis (severe difficulty breathing and shock), so if you have a known sensitivity to animal-derived enzymes, talk to your pharmacist first. The safety data advises against both ingredients during pregnancy and breastfeeding.

Side effects, ingredient by ingredient Trypsin Chymotrypsin

Meds to double-check

No known interactions
Known Interaction Concern · database check
No known interactions

No medication interactions are currently documented for the matched ingredients — that isn't a guarantee none exist.

Why this rating?
  • None of the 2 matched ingredients has a documented medication interaction on file.

No interactions are documented in our data for the ingredients we could check. Still, use the medication checker below with your exact drugs to be sure.

The bottom line

Scorecard at a glanceFormula with limited ingredient disclosure with no established evidence rating for its marketed use. No medication interactions are currently documented, and safety information is well characterized.

This is a short-term enzyme supplement with limited but some promising evidence (especially chymotrypsin for cataracts). If you're pregnant, breastfeeding, or have a history of allergies to animal enzymes, check with your pharmacist or doctor first.

Most people tolerate it, but stomach upset can happen — and rare severe allergic reactions have been reported.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 2 of 2 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Oct 24, 2022.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about Proteolytic Enzymes, straight from the product label.

Brand AMVILAB
Net contents 60 Capsule(s)
Market status On market
Date entered into DSLD Oct 24, 2022
DSLD ID 278222
Product type Non-nutrient/non-botanical
Supplement form Capsule
Dietary claims / uses All Other, Structure/Function
Intended target group(s) Adult (18 - 50 Years)
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for Proteolytic Enzymes by AMVILAB, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Adults and children 4 or more years of age
Minimum serving Sizes:
2 Vegetable Capsule(s)
Maximum serving Sizes:
2 Vegetable Capsule(s)
Servings per container
30
IngredientAmount% DV
Trypsin0 NP--
Chymotrypsin0 NP--

Other ingredients: Microcrystalline Cellulose, Hypromellose, Magnesium Stearate, Silicon Dioxide

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
Suggested/Recommended/Usage/Directions

Suggested Use: 2 capsules 3 times daily on an empty stomach or as directed by a healthcare professional.

Precautions

Caution: Do not exceed recommended dose.

Pregnant or nursing mothers, children under 18, and individuals with a known medical condition should consult a physician before using this or any dietary supplement.

Pregnant or nursing mothers, children under 18, and individuals with a known medical condition should consult a physician before using this or any dietary supplement.

This product is manufactured and packaged in a facility which may also process milk, soy, wheat, egg, peanuts, tree nuts, fish and crustacean shellfish.

Keep out of the reach of children.

Do not use if safety seal is damaged or missing.

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Storage

Store in a cool, dry place.

Formula

Trypsin & Chymotrypsin

Formulation

Helps support tissue health

Helps support: Protein metabolism pathway Immune system health Healthy circulatory function

Premium grade proteolytic enzyme formulation

FDA Statement of Identity

Dietary Supplement

Brand IP Statement(s)

DRcaps is a registered trademark of Capsugel

Seals/Symbols

Certified from a GMP Certified Facility Formulated in the USA Manufactured in an FDA Inspected Facility

See for yourself

Proteolytic Enzymes by AMVILAB label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

What’s inside

The Ingredients in Proteolytic Enzymes by AMVILAB

These are the 2 active ingredients this product is made of. Select any to open its full monograph.

Serving size2 Vegetable Capsule(s) Dosage formCapsule Servings per container30 Amounts shown are per serving.

Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.

Trypsin

No known
interactions
0 NP per serving

Trypsin is a protein-digesting enzyme usually taken from the pancreas of animals and used either by mouth (often combined with other enzymes like chym...

Trypsin monograph & interactions

Chymotrypsin

No known
interactions
0 NP per serving

Chymotrypsin is a protein-digesting (proteolytic) enzyme, usually taken from the pancreas of cattle or pigs, that is mainly used to help reduce swelli...

Chymotrypsin monograph & interactions

Other (inactive) ingredients: Microcrystalline Cellulose, Hypromellose, Magnesium Stearate, Silicon Dioxide. These complete the product’s ingredient list but are not active constituents.

Interaction report

Proteolytic Enzymes by AMVILAB Drug Interactions

We don’t currently list any known drug interactions for the mapped ingredients in Proteolytic Enzymes. This doesn’t guarantee none exist — always confirm with your pharmacist before combining a supplement with your medications.

The maker

Brand information

Manufacturer and brand details for Proteolytic Enzymes, from the product label.

AMVILAB

Name
Amvilab
Street Address
PO Box 52953
City
Atlanta
State
GA
ZipCode
30355
Web Address
www.amvilab.com
Pharmacist Counseling Corner

Proteolytic Enzymes by AMVILAB: Common Questions

Does Proteolytic Enzymes by AMVILAB interact with any medications?
We do not currently list a known interaction for the mapped ingredients in Proteolytic Enzymes. This does not guarantee none exist, so confirm with your pharmacist.
How can one product interact with so many drugs?
Proteolytic Enzymes contains 2 active ingredients, and an interaction can come from any of them. We check every ingredient, combine the results into one list per medication, and show which ingredient and mechanism is responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
Can I take this if I'm pregnant or breastfeeding?
The safety data advises against both trypsin and chymotrypsin during pregnancy and breastfeeding. Talk to your doctor or pharmacist for personalized advice before starting.
What are proteolytic enzymes and what do they do?
Proteolytic enzymes break down proteins in your body. Trypsin and chymotrypsin are digestive enzymes normally made by your pancreas. This product supplies them to support tissue repair and other functions.
Will this upset my stomach?
Trypsin taken with other enzymes (like in this product) can cause mild-to-moderate nausea, heartburn, or stomach pain in some people. It's not clear if trypsin alone or chymotrypsin causes these effects, but they're possible.
Can I have an allergic reaction to this?
Chymotrypsin is an animal-derived enzyme, and rare serious allergic reactions — including anaphylaxis — have been reported. If you have a known sensitivity to animal enzymes, talk to your pharmacist before taking it.
Does chymotrypsin really work for cataracts?
Yes — chymotrypsin is rated effective for cataracts in our data. The evidence for trypsin and chymotrypsin for other uses (sprains, osteoarthritis, wound healing, exercise soreness, MS) isn't established yet.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if Proteolytic Enzymes is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

Proteolytic Enzymes label
Sources

Sources & How We Checked

Proteolytic Enzymes's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 23 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Trypsin 17 references
  1. Burnham TH, ed. Drug Facts and Comparisons, Updated Monthly. Facts and Comparisons, St. Louis, MO.
  2. Latha B, Ramakrishnan M, Jayaraman V, Babu M. The efficacy of trypsin: chymotrypsin preparation in the reduction of oxidative damage during burn injury. Burns 1998;24:532-8. PubMed
  3. Latha B, Ramakrishnan M, Jayaraman V, Babu M. Serum enzymatic changes modulated using trypsin: chymotrypsin preparation during burn wounds in humans. Burns 1997;23:560-4. PubMed
  4. Klein, G., Kullich, W., Schnitker, J., and Schwann, H. Efficacy and tolerance of an oral enzyme combination in painful osteoarthritis of the hip. A double-blind, randomised study comparing oral enzymes with non-steroidal anti-inflammatory drugs. Clin Exp
  5. Dale, P. S., Tamhankar, C. P., George, D., and Daftary, G. V. Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects. Cancer Chemother.Pharmacol 2001;47 Suppl:S29-S34. PubMed
  6. Martin, T., Uhder, K., Kurek, R., Roeddiger, S., Schneider, L., Vogt, H. G., Heyd, R., and Zamboglou, N. Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial PubMed
  7. Miller, P. C., Bailey, S. P., Barnes, M. E., Derr, S. J., and Hall, E. E. The effects of protease supplementation on skeletal muscle function and DOMS following downhill running. J Sports Sci 2004;22(4):365-372. PubMed
  8. Bolten WW, Glade MJ, Raum S, Ritz BW. The safety and efficacy of an enzyme combination in managing knee osteoarthritis pain in adults: a randomized, double-blind, placebo-controlled trial. Arthritis 2015;2015:251521. PubMed
  9. US Department of Justice. U.S. Files Complaint Against Texas-Based Healthpoint Ltd. Under the False Claims Act. https://www.justice.gov/opa/pr/us-files-complaint-against-texas-based-healthpoint-ltd-under-false-claims-act. (Accessed June 19, 2019).
  10. Grabs V, Kersten A, Haller B, et al. Rutoside and hydrolytic enzymes do not attenuate marathon-induced inflammation. Med Sci Sports Exerc. 2017;49(3):387-395. PubMed
  11. Baumhackl U, Kappos L, Radue EW, et al. A randomized, double-blind, placebo-controlled study of oral hydrolytic enzymes in relapsing multiple sclerosis. Mult Scler. 2005;11(2):166-8. PubMed
  12. Gujral MS, Patnaik PM, Kaul R, et al. Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers. Cancer Chemother Pharmacol. 2001;47 Suppl:S23-8. PubMed
  13. Kempf K, Manzo G, Hanifi-Moghaddam P, et al. Effect of combined oral proteases and flavonoid treatment in subjects at risk of Type 1 diabetes. Diabet Med. 2009;26(12):1309-10. PubMed
  14. Kerkhoffs GM, Struijs PA, de Wit C, Rahlfs VW, Zwipp H, van Dijk CN. A double blind, randomised, parallel group study on the efficacy and safety of treating acute lateral ankle sprain with oral hydrolytic enzymes. Br J Sports Med. 2004;38(4):431-5. PubMed
  15. Popiela T, Kulig J, Klek S, Wachol D, Bock PR, Hanisch J. Double-blind pilot-study on the efficacy of enzyme therapy in advanced colorectal cancer. Przegl Lek. 2000;57 Suppl 5:142.
  16. Shetty V, Mohan A. A prospective, randomized, double-blind, placebo-controlled clinical trial comparing the efficacy of systemic enzyme therapy for edema control in orthognathic surgery using ultrasound scan to measure facial swelling. J Oral Maxillofac S PubMed
  17. Comparison of Chronic Wound Care Products. Pharmacist's Letter/Prescriber's Letter 2008;12(3):1203.

See these in context on the Trypsin monograph →

Chymotrypsin 6 references
  1. Martindale W. Martindale the Extra Pharmacopoeia. Pharmaceutical Press, 1999.
  2. Dukes, MNG. Meyler's Side Effects of Drugs. 13th ed. Elsevier: Amsterdam, 1997.
  3. Latha B, Ramakrishnan M, Jayaraman V, Babu M. Serum enzymatic changes modulated using trypsin: chymotrypsin preparation during burn wounds in humans. Burns 1997;23:560-4. PubMed
  4. Shaw PC. The use of a trypsin-chymotrypsin formulation in fractures of the hand. Br J Clin Pract 1969;23:25-6. DOI
  5. McCue FC, Webster TM, Gieck J. Clinical effects of proteolytic enzymes after reconstructive hand surgery. Int Surg 1972;57:479-82.
  6. Sun HJ, Xiao JQ, Qiao QH, et al. Chymotrypsin with sialendoscopy-assisted surgery for the treatment of chronic obstructive parotitis. Int J Oral Maxillofac Surg 2017;46(7):877-82. doi: 10.1016/j.ijom.2017.02.1267. PubMed

See these in context on the Chymotrypsin monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring